Jamjoom Pharmaceuticals Factory Co.
Last Updated:
- 146.40 SAR
- -3.40
- -2.27%
شركة مصنع جمجوم للأدوية
جمجوم فارما
Symbol :
4015
ISIN :
SA15QGU1UNH6
52-Week Range :
104.60
-
202.40
Turnover Ratio :
1.19
Market :
Saudi Exchange
Sector :
Pharma, Biotech & Life Science
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Jamjoom Pharmaceuticals Factory Co. (known as: JAMJOOM PHARMA) is a public company, listed on Saudi Exchange “Tadawul” (TDWL) since June 2023. JAMJOOM PHARMA operats within the pharmaceuticals Research...
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :SA15QGU1UNH6
-
Contact Person :
-
Established On:22-Sep-1994
-
Stock Listing On :20-Jun-2023
-
No of Employees :1,370 Employees as of 2023
-
Outstanding Shares :70,000,000
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2023 | Pharma, Biotech & Life Science | Saudi Exchange Co |
| Join | 2023 | Tadawul All Share Index (TASI) | Saudi Exchange Co |
| Jamjoom Pharmaceuticals Factory Co. |
| Jeddah Industrial City, Phase Five, Plot Three M A, PO Box 006267, Jeddah 21442, Kingdom Saudi Arabia |
| T : +966 12 6140099 |
| F : +966 12 6140088 |
| www.jamjoompharma.com |
| ir@jamjoompharma.com |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Mahmoud Jamjoom | 2022 |
| CEO: | Tarek Hosni | 2021 |
| Deputy Chairman: | Ahmed Jamjoom | 2022 |
| Board Member: | Georges Schorderet | 2023 |
| Noor Sheriff | 2022 | |
| Mohammed Jamjoom | 2022 | |
| Alaa Jamjoom | 2022 | |
| Faris Al Ghannam | 2022 | |
| Yousuf Jamjoom | 2022 | |
| Michel Le Bars | 2022 |
Reports
| Date | Title | File |
|---|---|---|
| 2024 | JAMJOOM PHARMA Quarterly Financials Report Q3 2024 | |
| 2024 | Jamjoom Pharma reports SAR 305 million net profit in 9M 2024, up 23% YoY | |
| 2024 | JAMJOOM PHARMA Quarterly Financials Report Q2 2024 | |
| 2024 | Jamjoom Pharma reports SAR 210 million net profit in 1H 2024, up 23% YoY | |
| 2024 | JAMJOOM PHARMA Quarterly Financials Report Q1 2024 | |
| 2024 | Jamjoom Pharma reports 22.0% Net Profit growth to SAR 103.0 million in 1Q 2024 | |
| 2024 | JAMJOOM PHARMA Annual Financials Report 2023 | |
| 2024 | Jamjoom Pharma reports 71% net profit growth to SAR292.4 million in 2023 | |
| 2023 | JAMJOOM PHARMA Quarterly Financials Report Q3 2023 | |
| 2023 | Jamjoom Pharma reports 78% net profit growth to SAR 248 million in 9M 2023 | |
| 2023 | JAMJOOM PHARMA Quarterly Financials Report Q2 2023 |
